CAn a drug against cholesteRol work as aDjuvant in anticancer therapy? A novel therapeutic applicatIOn of SIMvastatin against DOXorubicin-induced cardiotoxicity

Project

Overview

Contributor (2)

MINCIONE Gabriella   Scientific Manager  
TINARI Nicola   Participant  

Representatives (2)

DI FALCO Luciano   Administrative  
DI PAOLO Marino   Administrative  

Leading department (2)

Term type

PNRR Ecosistemi dell'innovazione

Financier

Università degli Studi di FIRENZE

Partner

Università degli Studi di SALERNO

Total Contribution (assigned) University (EUR)

159,310€

Date/time interval

July 25, 2024 - October 24, 2025

Project duration

15 months

Research

Concepts (3)

Free text keywords (3)

cardiotossicità
doxorubicina
simvastatina
No Results Found

Outputs

Outputs (3)

SIMVASTATIN as a potential protective strategy against doxorubicin-induced cardiotoxicity 
FRONTIERS IN CARDIOVASCULAR MEDICINE
2026
Academic Article
none Access
Altmetric is disabled. Enable it on "Use of Cookies"
Simvastatin Attenuates Doxorubicin-Induced Inflammation in Human Cardiomyocytes 
BIOMEDICINES
2026
Academic Article
none Access
Altmetric is disabled. Enable it on "Use of Cookies"
Cardioprotective Effects of Simvastatin in Doxorubicin-Induced Acute Cardiomyocyte Injury 
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2025
Academic Article
Open Access
Altmetric is disabled. Enable it on "Use of Cookies"